AngioDynamics Reports Record FY2026 Results, Double-Digit MedTech Growth
AngioDynamics reported record fiscal year 2026 results with Med Tech revenue growing over 18%. The company achieved positive adjusted EBITDA while navigating tariff-related headwinds.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day